Статья
Особенности профилактического консультирования больных ИБС с абдоминальным ожирением
Больные ИБС с абдоминальным ожирением (АО) являются приоритетной группой для наиболее активного проведения мероприятий по вторичной профилактике. Статья посвящена актуальным вопросам коррекции кардиоваскулярных ФР с применением комплексных профилактических программ кардиореабилитации (КР) у больных ИБС с АО. Согласно результатам крупных рандомизированных клинических исследований интенсивные поведенческие вмешательства в виде консультирования, особенно на этапе долгосрочной поддержки, эффективны у этой категории больных, они производят пусть небольшие, но важные изменения поведения в отношении здоровья (в снижении массы тела, в отношении питания и физической активности), а также улучшают отдельные промежуточные клинические конечные точки.
1. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence ofoverweight and obesity in the United States, 1999-2004. JAMA. 2006;295 (13):1549-55. DOI:10.1001/jama. 295.13.1549.
2. Audelin MC, Savage PD, Ades PA. Changing clinical profile of patients entering cardiac rehabilitation/secondary prevention programs: 1996 to 2006. J Cardiopulm Rehabil Prev. 2008;28 (5):299-306. DOI:10.1097/01. HCR. 0000336139.48698.26.
3. Бритов А. Н., Поздняков Ю. М., Волкова Э. Г., Драпкина О. М., Еганян Р. А., Кисляк О. М. и др. Национальные рекомендации по кардиоваскулярной профилактике. Кардиоваскулярная Терапия И Профилактика. 2011;10 (6 S2):2-64.
4. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016; 37 (29) :2315-81. DOI:10.1093/eurheartj/ehw106.
5. Martinez-Gonzalez MA, Garcia-Arellano A, Toledo E, Bes-Rastrollo M, Bullo M, Corella D et al. Obesity indexes and total mortality among elderly subjects at high cardiovascular risk: the PREDIMED study. PLoS ONE. 2014;9 (7):e103246. DOI:10.1371 /journal. pone. 0103246.
6. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364 (9438):937-52. DOI:10.1016/S0140-6736 (04) 17018-9.
7. Sharma S, Batsis JA, Coutinho T, Somers VK, Hodge DO, Carter RE et al. Normal-weight central obesity and mortality risk inolder adults with coronary artery disease. Mayo Clin Proc. 2016;91 (3):343-51. DOI:10.1016/j. mayocp. 2015.12.007.
8. Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration (BMI Mediated Effects), Lu Y, Hajifathalian K, Ezzati M, Woodward M, Rimm EB et al. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with L8 million participants. Lancet. 2014;383 (9921):970-83. DOI:10.1016/S0140-6736 (13) 61836-X.
9. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9-1 million participants. Lancet. 2011;377 (9765):557-67. DOI:10.1016/S0140-6736 (10) 62037-5.
10. Ades PA, Savage PD, Toth MJ, Harvey-Berino J, Schneider DJ, Bunn JY et al. High-calorie-expenditure exercise: a new approach to cardiac rehabilitation for overweight coronary patients. Circulation. 2009; 119 (20):2671-8. DOI: 10.1161 / CIRCULATIONAHA. 108.834184.
11. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RE, Lachin JM, Walker EA et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346 (6):393-403. DOI:10.1056/NEJMoa012512.
12. Aguilar D. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the valsartan in acute myocardial infarction (VALIANT) trial. Circulation. 2004;110 (12):1572-8. DOI:10.1161/01. CIR. 0000142047.28024. F2.
13. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U et al. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil. 2009; 16 (2):121-37. DOI:10.1097/HJR. 0b013e3283294b1d.
14. Kotseva K, Wood D, De Bacquer D, De Backer G, Rydén L,Jennings C et al. EUROASPIRE IV: a European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol. 2016;23 (6) :636-48. DOI: 10.1177/2047487315569401
15. Погосова Н. В., Оганов Р. Г., Бойцов С. А., Аушева А. К., Соколова О. Ю., Курсаков А. А. и др. Мониторинг вторичной профилактики ишемической болезни сердца в России и Европе: результаты российской части международного многоцентрового исследования EUROASPIRE IV. Кардиология. 2015;55 (12):99-107.
16. ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. European Heart Journal. 2013;34 (38):2949-3003. DOI:10.1093/eurheartj/eht296.
17. Gibbons RJ, Chatterjee K, DaleyJ, Douglas JS, Fihn SD, Gardin JM et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). J Am Coll Cardiol. 1999;33 (7):2092-197.
18. Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012;60 (24):e44-164. DOI:10.1016/j. jacc. 2012.07.013.
19. Anderson L, Brown JP, Clark AM, Dalal H, Rossau HK, Bridges C et al. Patient education in the management of coronary heart disease. Cochrane Database Syst Rev. 2017;6: CD008895. DOI: 10.1002/14651858. CD008895. pub3.
20. Ghisi GL de M, Abdallah F, Grace SL, Thomas S, Oh P. A systematic review of patient education in cardiac patients: do they increase knowledge and promote health behavior change? Patient Educ Couns. 2014;95 (2):160-74. DOI:10.1016/j. pec. 2014.01.012.
21. LeFevre ML, U. S. Preventive Services Task Force. Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: U. S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2014;161 (8):587-93. DOI:10.7326/M14-1796.
22. Погосова Г. В., Калинина А. М., Спивак Е. Ю., Назаркина В. А. Эффективность образовательной профилактической технологии у больных стабильной стенокардией в амбулаторных условиях. Кардиология. 2008;48 (7):4-9.
23. Deakin T, McShane CE, Cade JE, Williams RDRR. Group based training for self-management strategies in people with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2005; (2):CD003417. DOI: 10.1002/14651858. CD003417. pub2.
24. Wood DA, Kotseva K, Connolly S,Jennings C, Mead A, Jones J et al. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial. Lancet. 2008;371 (9629):1999-2012. DOI:10.1016/S0140-6736 (08) 60868-5.
25. Tierney S, Mamas M, Woods S, Rutter MK, Gibson M, Neyses L et al. What strategies are effective for exercise adherence in heart failure? A systematic review of controlled studies. Heart Fail Rev. 2012;17 (1):107-15.DOI:10.1007/s10741-011-9252-4.
26. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008; (2):CD000011. DOI:10.1002/14651858. CD000011. pub3.
27. Rubak S, Sandbaek A, Lauritzen T, Christensen B. Motivational interviewing: a systematic review and meta-analysis. Br J Gen Pract. 2005;55 (513):305-12.
28. Behaviour change: individual approaches | Guidance and guidelines | NICE.. Available from: https:// www.nice.org.uk/guidance/ph49URL https://www.nice.org.uk/ guidance/ph49 (accessed 12.18.17).
29. Eilat-Adar S, Eldar M, Goldbourt U. Association of intentional changes in body weight with coronary heart disease event rates in overweight subjects who have an additional coronary risk factor. Am J Epidemiol. 2005;161 (4):352-8. DOI:10.1093/aje/kwi045.
30. Ross R, Dagnone D, Jones PJ, Smith H, Paddags A, Hudson R et al. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med. 2000;133 (2):92-103.
31. Milani RV, Lavie CJ. Prevalence and profile of metabolic syndrome in patients following acute coronary events and effects of therapeutic lifestyle change with cardiac rehabilitation. Am J Cardiol. 2003;92 (1):50-4.
32. Brochu M, Poehlman ET, Savage P, Fragnoli-Munn K, Ross S, Ades PA. Modest effects of exercise training alone on coronary risk factors and body composition in coronary patients. J Cardiopulm Rehabil. 2000;20 (3):180-8.
33. Woodruff RC, Schauer GL, Addison AR, Gehlot A, Kegler MC. Barriers to weight loss among community health center patients: qualitative insights from primary care providers. BMC Obes. 2016;3:43. DOI: 10.1186/s40608-016-0123-3.
34. Sharifi N, Mahdavi R, Ebrahimi-Mameghani M. Perceived barriers to weight loss programs for overweight or obese women. Health Promot Perspect. 2013;3 (1):11-22. DOI:10.5681/hpp. 2013.002.
35. Ades PA, Savage PD, Harvey-Berino J. The treatment of obesity in cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2010;30 (5):289-98. DOI:10.1097/HCR. 0b013e3181d6f9a8.
36. Mertens DJ, Kavanagh T, Campbell RB, Shephard RJ. Exercise without dietary restriction as a means to long-term fat loss in the obese cardiac patient. J Sports Med Phys Fitness. 1998;38 (4):310-6.
37. Anderson L, Sharp GA, Norton RJ, Dalal H, Dean SG, Jolly K et al. Home-based versus centre-based cardiac rehabilitation. Cochrane Database Syst Rev. 2017;6: CD007130. DOI:10.1002/14651858. CD007130. pub4.
38. Eysenbach G, CONSORT-EHEALTH Group. CONSORT-EHEALTH: improving and standardizing evaluation reports of Web-based and mobile health interventions. J Med Internet Res. 2011;13 (4):e126. DOI:10.2196/jmir. 1923.
39. Park M-J, Kim H-S. Evaluation of mobile phone and Internet intervention on waist circumference and blood pressure in post-menopausal women with abdominal obesity. Int J Med Inform. 2012;81 (6):388-94. DOI:10.1016/j. ijmedinf. 2011.12.011.
40. Vermunt PWA, Milder IEJ, Wielaard F, Baan CA, Schelfhout JDM, Westert GP et al. Behavior change in a lifestyle intervention for type 2 diabetes prevention in Dutch primary care: opportunities for intervention content. BMC Fam Pract. 2013; 14:78. DOI:10.1186/1471-2296-14-78.
41. Pellegrini CA, Steglitz J, Johnston W, Warnick J, Adams T, McFadden HG et al. Design and protocol of a randomized multiple behavior change trial: Make Better Choices 2 (MBC2). Contemp Clin Trials. 2015;41:85-92. DOI:10.1016/j. cct. 2015.01.009.
42. Varnfield M, Karunanithi M, Lee C-K, Honeyman E, Arnold D, Ding H et al. Smartphone-based home care model improved use of cardiac rehabilitation in postmyocardial infarction patients: results from a randomised controlled trial. Heart. 2014;100 (22): 1770-9. DOI:10.1136/heartjnl-2014-305783.